UTMD
Utah Medical Products, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-27
Figures on this page computed 2026-11-08 12:40 UTC
Last close
72.42USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-03-27
20.8xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-27
26.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
29.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
37.2%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
0.004Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
1.7%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2025, filed 2026-03-27
Growth is the furthest below its sector's middle: 0.28 against 0.47 on the market's range.
Against its rival
lens 4 of 9Measure by measure
behind on 2 of 4- Profit on each unit of sales29.3%17.6%Ahead
Higher is better here.
- Return on the capital it uses26.8%n/an/a
Higher is better here.
- Sales growth over five years-1.8%15.3%Behind
Higher is better here.
- Debt against equity0.00n/an/a
Lower is better here.
- Gross margin57.1%31.4%Ahead
Higher is better here.
- Price against earnings20.8x14.9xBehind
Lower is better here.
The first column is this company and the second is the one it is set against. A measure only one of the two reports is left at n/a rather than counted as a win.
Against Pro-Dex, Inc., UTMD is behind on 2 of 4 measures.
Against Pro-Dex, Inc., UTMD is behind on 2 of 4 measures.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-03-27
Profit on each unit of sales29.3%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
Return on the capital it uses26.8%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
Sales growth over five years-1.8%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
Debt against equity0.004
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
Gross margin57.1%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD
Price against earnings20.8x
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001096906-26-000395
- Reported in
- USD